We are live on ! Find out more
MAM

Monaco Asset Management Portfolio holdings

AUM $1.26B
1-Year Est. Return 60.23%
This Fund
S&P 500
This Quarter Est. Return
+0.59%
1 Year Est. Return
+60.23%
3 Year Est. Return
+119.64%
5 Year Est. Return
10 Year Est. Return
AUM
$627M
AUM Growth
+$293M
Cap. Flow
-$26.5M
Cap. Flow %
-4.22%
Top 10 Hldgs %
78.72%
Holding
74
New
18
Increased
16
Reduced
19
Closed
12

Top Buys

Rank Stock Value
1
NEM icon
Newmont
NEM
+$18.2M
2
DNA icon
Ginkgo Bioworks
DNA
+$7.31M
3
MU icon
Micron Technology
MU
+$6.43M
4
PYPL icon
PayPal
PYPL
+$6.04M
5
BIDU icon
Baidu
BIDU
+$4.27M

Sector Composition

Rank Sector Weight
1 Miscellaneous 71.87%
2 Healthcare 9.81%
3 Materials 9.66%
4 Technology 4.11%
5 Communication Services 2.12%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CPRI icon
26
Capri Holdings
CPRI
$1.7B
$2.98M 0.47%
+90,000
New +$3.26M
ZYME icon
27
Zymeworks
ZYME
$1.97B
$2.86M 0.46%
336,344
+43,844
+15% +$390K
NKTR icon
28
Nektar Therapeutics
NKTR
$2.33B
$2.69M 0.43%
144,429
-244,342
-63% -$5.15M
GOSS icon
29
Gossamer Bio
GOSS
$73M
$2.46M 0.39%
34,076
+27,126
+390% +$1.62M
PSLV icon
30
Sprott Physical Silver Trust
PSLV
$13.4B
$2.28M 0.36%
230,000
BTG icon
31
B2Gold
BTG
$7.13B
$2.16M 0.34%
800,000
+182,815
+30% +$494K
ORIC icon
32
Oric Pharmaceuticals
ORIC
$1.34B
$2.13M 0.34%
301,650
+171,650
+132% +$1.54M
AAPL icon
33
PUT
Apple
AAPL
$4.92T
$2.11M 0.34%
10,000
MSOS icon
34
AdvisorShares Pure US Cannabis ETF
MSOS
$977M
$1.85M 0.3%
252,712
-114,788
-31% -$1M
NBIS
35
Nebius Group N.V.
NBIS
$59.3B
$1.56M 0.25%
105,000
PRGO icon
36
Perrigo
PRGO
$1.87B
$1.54M 0.25%
+60,000
New +$1.76M
CIEN icon
37
Ciena
CIEN
$48.8B
$1.45M 0.23%
30,000
+12,500
+71% +$593K
MRVI icon
38
Maravai LifeSciences
MRVI
$1.08B
$1.43M 0.23%
200,000
+41,849
+26% +$361K
MREO
39
Mereo BioPharma
MREO
$46.3M
$1.25M 0.2%
348,128
-56,872
-14% -$184K
TDOC icon
40
Teladoc Health
TDOC
$1.14B
$1.22M 0.19%
+125,000
New +$1.52M
VNDA icon
41
Vanda Pharmaceuticals
VNDA
$309M
$1.09M 0.17%
+192,926
New +$996K
NVAX icon
42
Novavax
NVAX
$1.65B
$1.08M 0.17%
85,000
-103,900
-55% -$1.05M
QDEL icon
43
QuidelOrtho
QDEL
$761M
$1.04M 0.17%
+31,253
New +$1.28M
FET icon
44
Forum Energy Technologies
FET
$944M
$1M 0.16%
59,604
SOL
45
DELISTED
Emeren Group
SOL
$972K 0.15%
647,745
-522,255
-45% -$957K
MAG
46
DELISTED
MAG Silver
MAG
$959K 0.15%
82,200
FATE icon
47
Fate Therapeutics
FATE
$302M
$941K 0.15%
286,900
-29,905
-9% -$131K
PARA
48
DELISTED
Paramount Global Class B
PARA
$883K 0.14%
85,000
-45,000
-35% -$527K
XPER icon
49
Xperi
XPER
$270M
$859K 0.14%
+104,660
New +$989K
NGD
50
DELISTED
New Gold Inc
NGD
$858K 0.14%
440,000
+35,000
+9% +$66.5K

Similar funds

Monaco Asset Management's Q2 2024 Portfolio in Review

As of Q2 2024, Monaco Asset Management held 74 positions worth $627M, up 88% from $334M the previous quarter. Its ten largest holdings account for 79% of the portfolio.

Monaco Asset Management withdrew a net $26.5M in Q2 2024, closing 12 positions and reducing 19 holdings. Its most notable exit was Alibaba, an estimated $4.7M position sold in full.

By sector, the portfolio is most concentrated in Miscellaneous at 72% of assets, up from 44% a quarter earlier, followed by Healthcare and Materials.

Against the trend, Monaco Asset Management opened a new position in Ginkgo Bioworks worth $3.28M.

  • Monaco Asset Management's largest Q2 2024 buy was Ginkgo Bioworks: 245,000 shares worth $3.28M.
  • Monaco Asset Management added most to Newmont in Q2 2024, an estimated $18.2M increase.
  • Monaco Asset Management's biggest Q2 2024 reduction was Alcoa, cutting an estimated $18.1M.
  • Monaco Asset Management fully exited Alibaba in Q2 2024, selling an estimated $4.7M.
  • Monaco Asset Management's ten largest holdings make up 79% of its $627M portfolio in Q2 2024.
  • Monaco Asset Management opened 18 new positions and closed 12 in Q2 2024.
  • Monaco Asset Management's portfolio value rose 88% quarter-over-quarter to $627M.

Based on Monaco Asset Management's 13F filing for Q2 2024, filed 7 Aug 2024.